Rising rates of cancer are going to come at a major cost, and it's looking more and more like the solution is going to have ...

The Beat AML Master Trial found high remission rates and promising safety with triplet therapy in patients with acute myeloid leukemia (AML), according to Ashley Yocum, PhD.